|
|
Effect of SDF-1α on the migration of mesenchymal stem cells |
XIE Gui-qin, XU Xiao-jing, ZHANG Huan-xiang |
(Department of Cell Biology, Basic Medical and Biological College of Soochow University, Suzhou Jiangsu 215123,China) |
|
|
Abstract Objective: To investigate the effect of stromal cell-derived factor-1α (SDF-1α) on the migration of mesenchymal stem cells (MSCs) and the mechanism involved in cell migration. Methods: MSCs were isolated from rat bone marrow in vitro. Boyden chamber was used to study the behavior of cell migration toward SDF-1α at different concentrations (0, 5, 25, 50, and 100 ng/mL). Then, we detected the phosphorylation of PI3K/Akt and MAPKs by addition of SDF1α by Western blot. Finally, pretreatment with specific chemical inhibitors to block PI3K/Akt or MAPKs signaling,we analyzed the influence of these signaling on SDF-1α-induced cell migration by Boyden chamber. Results: SDF-1α at different concentrations influenced MSCs migration by the regulation of PI3K/Akt and MAPKs signaling, and low concentrations of SDF-1α were positive related to cell migration, while high concentrations played converse effect. Interference with basal PI3K/Akt or MAPKs signaling decreased SDF-1α-induced MSCs migration to a variable extent. Conclusion: SDF-1α-induced MSCs migration was positively regulated to the changing of PI3K/Akt signaling. Meanwhile, blocking JNK/SAPK signaling significantly decreased SDF-1α-induced directed migration of MSCs. Treatment with SDF-1α could promote ERK1/2 and p38MAPK signaling pathways in MSCs, yet interference with the two signaling had no significant inhibition of cell migration.
|
Received: 03 June 2014
|
|
|
|
[1]Black IB,Woodbury D. Adult rat and human bone marrow stromal stem cells differentiate into neurons\[J\]. Blood Cells Mol Dis, 2001,27(3): 632-636.[2]Woodbury D, Schwarz EJ, Prockop DJ, et al. Adult rat and human bone marrow stromal cells differentiate into neurons\[J\]. J Neurosci Res, 2000,61(4): 364-370.[3]Harting MT, Jimenez F, Xue H, et al. Intravenous mesenchymal stem cell therapy for traumatic brain injury\[J\]. J Neurosurg, 2009, 110(6): 1189-1197.[4]Forte G, Minieri M, Cossa P, et al. Hepatocyte growth factor effects on mesenchymal stem cells: proliferation, migration, and differentiation\[J\]. Stem Cells, 2006, 24(1): 23-33.[5]Sordi V, Malosio ML, Marchesi F, et al. Bone marrow mesenchymal stem cells express a restricted set of functionally active chemokine receptors capable of promoting migration to pancreatic islets\[J\]. Blood, 2005, 106(2): 419-427.[6]Ghadge SK, Muhlstedt S, Ozcelik C, et al. SDF-1α as a therapeutic stem cell homing factor in myocardial infarction\[J\]. Pharmacol Ther, 2011, 129(1): 97-108.[7]Imitola J, Raddassi K, Park KI, et al. Directed migration of neural stem cells to sites of CNS injury by the stromal cell-derived factor 1α/CXC chemokine receptor 4 pathway\[J\]. Proc Natl Acad Sci U S A, 2004, 101(52): 18117-18122.[8]Vandervelde S, van Luyn MJ, Tio RA, et al. Signaling factors in stem cell-mediated repair of infarcted myocardium\[J\]. J Mol Cell Cardiol, 2005, 39(2): 363-376.[9]Veit C, Genze F, Menke A, et al. Activation of phosphatidylinositol 3kinase and extracellular signalregulated kinase is required for glial cell line-derived neurotrophic factorinduced migration and invasion of pancreatic carcinoma cells\[J\]. Cancer Res, 2004, 64(15): 5291-5300.[10]Wang JF, Park IW, Groopman JE. Stromal cell-derived factor-1α stimulates tyrosine phosphorylation of multiple focal adhesion proteins and induces migration of hematopoietic progenitor cells: roles of phosphoinositide-3 kinase and protein kinase C\[J\]. Blood, 2000, 95(8): 2505-2513.[11]Segarra J, Balenci L, Drenth T, et al. Combined signaling through ERK, PI3K/AKT, and RAC1/p38 is required for met-triggered cortical neuron migration\[J\]. J Biol Chem, 2006, 281(8): 4771-4778.[12]Liu ZL, Mao JH, Peng AF, et al. Inhibition of fatty acid synthase suppresses osteosarcoma cell invasion and migration via downregulation of the PI3K/Akt signaling pathway in vitro\[J\]. Mol Med Rep, 2013, 7(2): 608-612.[13]Bullone M, Moran K, Lavoie-Lamoureux A, et al. PI3K and MAPKs regulate neutrophil migration toward the airways in heaves\[J\]. J Vet Intern Med, 2013, 27(1): 164-170.[14]Ji JF, He BP, Dheen ST, et al. Interactions of chemokines and chemokine receptors mediate the migration of mesenchymal stem cells to the impaired site in the brain after hypoglossal nerve injury\[J\]. Stem Cells, 2004, 22(3): 415-427.[15]Coffelt SB, Marini FC, Watson K, et al. The proinflammatory peptide LL-37 promotes ovarian tumor progression through recruitment of multipotent mesenchymal stromal cells\[J\]. Proc Natl Acad Sci U S A, 2009, 106(10): 3806-3811.[16]Spaeth E, Klopp A, Dembinski J, et al. Inflammation and tumor microenvironments: defining the migratory itinerary of mesenchymal stem cells\[J\]. Gene Ther, 2008, 15(10): 730-738.[17]Alexanian AR, Maiman DJ, Kurpad SN, et al. In vitro and in vivo characterization of neurally modified mesenchymal stem cells induced by epigenetic modifiers and neural stem cell environment\[J\]. Stem Cells Dev, 2008, 17(6): 1123-1130.[18]CroitoruLamoury J, Williams KR, Lamoury FM, et al. Neural transplantation of human MSC and NT2 cells in the twitcher mouse model\[J\]. Cytotherapy, 2006, 8(5): 445-458.[19]di Bonzo LV, Ferrero I, Cravanzola C, et al. Human mesenchymal stem cells as a two-edged sword in hepatic regenerative medicine: engraftment and hepatocyte differentiation versus profibrogenic potential\[J\]. Gut, 2008, 57(2): 223-231.[20]Psaltis PJ, Zannettino AC, Worthley SG, et al. Concise review: mesenchymal stromal cells: potential for cardiovascular repair\[J\]. Stem Cells, 2008, 26(9): 2201-2210.[21]van Poll D, Parekkadan B, Cho CH, et al. Mesenchymal stem cell-derived molecules directly modulate hepatocellular death and regeneration in vitro and in vivo\[J\]. Hepatology, 2008, 47(5): 1634-1643.[22]Zheng H, Dai T, Zhou B, et al. SDF-1α/CXCR4 decreases endothelial progenitor cells apoptosis under serum deprivation by PI3K/Akt/eNOS pathway\[J\]. Atherosclerosis, 2008, 201(1): 36-42.[23]Liu N, Tian J, Cheng J, et al. Migration of CXCR4 gene-modified bone marrow-derived mesenchymal stem cells to the acute injured kidney\[J\]. J Cell Biochem, 2013, 114(12): 2677-2689.[24]Chen Y, Wei Y, Liu J, et al. Chemotactic responses of neural stem cells to SDF-1α correlate closely with their differentiation status\[J\]. J Mol Neurosci, 2014.\[Epub ahead of print\][25]梁光波, 张国平, 金惠铭. 碱性成纤维细胞成长因子对ECV304细胞迁移的影响\[J\]. 中国病理生理杂志, 2005, 21 (1) : 16-20.[26]Yin Q, Jin P, Liu X, et al. SDF-1α inhibits hypoxia and serum deprivation-induced apoptosis in mesenchymal stem cells through PI3K/Akt and ERK1/2 signaling pathways\[J\]. Mol Biol Rep, 2011, 38 (1) : 9-16.[27]Pan F, Ma S, Cao W, et al. SDF-1α upregulation of MMP-2 is mediated by p38 MAPK signaling in pancreatic cancer cell lines\[J\]. Mol Biol Rep, 2013, 40 (7) : 4139-4146. |
[1] |
ZHAO Chuan-xiang, LI Hong-hui, TANG Si-yi, WU Yi, LI Ci, GAO Feng-wei,ZHOU Jing-wen, QIU Xin, ZHANG Yan, XIA Sheng. Mesenchymal stem cell culture supernatant inhibits senescence of fibroblasts[J]. Journal of Jiangsu University(Medicine Edition), 2019, 29(01): 12-16. |
|
|
|
|